| A hypomorphic mouse model of dystrophic epidermolysis bullosa reveals mechanisms of disease and response to fibroblast therapy A Fritsch, S Loeckermann, JS Kern, A Braun, MR Bösl, TA Bley, ... The Journal of clinical investigation 118 (5), 1669-1679, 2008 | 227 | 2008 |
| Collagen VII plays a dual role in wound healing A Nyström, D Velati, VR Mittapalli, A Fritsch, JS Kern, ... The Journal of clinical investigation 123 (8), 3498-3509, 2013 | 202 | 2013 |
| Losartan ameliorates dystrophic epidermolysis bullosa and uncovers new disease mechanisms A Nyström, K Thriene, V Mittapalli, JS Kern, D Kiritsi, J Dengjel, ... EMBO molecular medicine 7 (9), 1211-1228, 2015 | 173 | 2015 |
| S2k guideline for the diagnosis of pemphigus vulgaris/foliaceus and bullous pemphigoid E Schmidt, M Goebeler, M Hertl, M Sárdy, C Sitaru, R Eming, SC Hofmann, ... JDDG: Journal der Deutschen Dermatologischen Gesellschaft 13 (7), 713-727, 2015 | 170 | 2015 |
| Mechanisms of fibroblast cell therapy for dystrophic epidermolysis bullosa: high stability of collagen VII favors long-term skin integrity JS Kern, S Loeckermann, A Fritsch, I Hausser, W Roth, TM Magin, C Mack, ... Molecular Therapy 17 (9), 1605-1615, 2009 | 137 | 2009 |
| Expanding the COL7A1 mutation database: novel and recurrent mutations and unusual genotype–phenotype constellations in 41 patients with dystrophic epidermolysis bullosa JS Kern, J Kohlhase, L Bruckner-Tuderman, C Has Journal of investigative dermatology 126 (5), 1006-1012, 2006 | 135 | 2006 |
| S2k guidelines for the treatment of pemphigus vulgaris/foliaceus and bullous pemphigoid R Eming, M Sticherling, SC Hofmann, N Hunzelmann, JS Kern, H Kramer, ... Journal der Deutschen Dermatologischen Gesellschaft= Journal of the German …, 2015 | 122 | 2015 |
| Global remodelling of cellular microenvironment due to loss of collagen VII V Küttner, C Mack, KTG Rigbolt, JS Kern, O Schilling, H Busch, ... Molecular systems biology 9 (1), 657, 2013 | 113 | 2013 |
| Injury-driven stiffening of the dermis expedites skin carcinoma progression VR Mittapalli, J Madl, S Löffek, D Kiritsi, JS Kern, W Römer, A Nyström, ... Cancer research 76 (4), 940-951, 2016 | 108 | 2016 |
| Chronic colitis due to an epithelial barrier defect: the role of kindlin‐1 isoforms JS Kern, C Herz, E Haan, D Moore, S Nottelmann, T Von Lilien, P Greiner, ... The Journal of Pathology: A Journal of the Pathological Society of Great …, 2007 | 99 | 2007 |
| Molecular mechanisms of phenotypic variability in junctional epidermolysis bullosa D Kiritsi, JS Kern, H Schumann, J Kohlhase, C Has, L Bruckner-Tuderman Journal of medical genetics 48 (7), 450-457, 2011 | 95 | 2011 |
| Forty‐two novel COL7A1 mutations and the role of a frequent single nucleotide polymorphism in the MMP1 promoter in modulation of disease severity in a large … JS Kern, G Grüninger, R Imsak, ML Müller, H Schumann, D Kiritsi, ... British Journal of Dermatology 161 (5), 1089-1097, 2009 | 95 | 2009 |
| Bullous pemphigoid in infants: characteristics, diagnosis and treatment A Schwieger-Briel, C Moellmann, B Mattulat, F Schauer, D Kiritsi, ... Orphanet journal of rare diseases 9, 1-12, 2014 | 88 | 2014 |
| S2k guidelines for the treatment of pemphigus vulgaris/foliaceus and bullous pemphigoid: 2019 update E Schmidt, M Sticherling, M Sárdy, R Eming, M Goebeler, M Hertl, ... JDDG: Journal der Deutschen Dermatologischen Gesellschaft 18 (5), 516-526, 2020 | 84 | 2020 |
| Basics of immunohistochemistry V Schacht, JS Kern Journal of investigative dermatology 135 (3), 1-4, 2015 | 84 | 2015 |
| Calculation of cut‐off values based on the Autoimmune Bullous Skin Disorder Intensity Score (ABSIS) and Pemphigus Disease Area Index (PDAI) pemphigus scoring systems for … C Boulard, S Duvert Lehembre, C Picard‐Dahan, JS Kern, G Zambruno, ... British Journal of Dermatology 175 (1), 142-149, 2016 | 73 | 2016 |
| Large international validation of ABSIS and PDAI pemphigus severity scores V Hebert, C Boulard, E Houivet, SD Lehembre, L Borradori, R Della Torre, ... Journal of investigative dermatology 139 (1), 31-37, 2019 | 62 | 2019 |
| Biglycan expression in the melanoma microenvironment promotes invasiveness via increased tissue stiffness inducing integrin-β1 expression H Andrlová, J Mastroianni, J Madl, JS Kern, W Melchinger, H Dierbach, ... Oncotarget 8 (26), 42901, 2017 | 60 | 2017 |
| Proof of concept for the clinical effects of oral rilzabrutinib, the first Bruton tyrosine kinase inhibitor for pemphigus vulgaris: the phase II BELIEVE study DF Murrell, A Patsatsi, P Stavropoulos, S Baum, T Zeeli, JS Kern, ... British Journal of Dermatology 185 (4), 745-755, 2021 | 50 | 2021 |
| TGM5 mutations impact epidermal differentiation in acral peeling skin syndrome M Pigors, D Kiritsi, C Cobzaru, A Schwieger-Briel, J Suárez, F Faletra, ... Journal of investigative dermatology 132 (10), 2422-2429, 2012 | 50 | 2012 |
Kiritsi, DimitraVerified email at uniklinik-freiburg.de
